Conaway M - Search Results

1

The MG Composite: A valid and reliable outcome measure for myasthenia gravis.

Burns TM, Conaway M, Sanders DB; MG Composite and MG-QOL15 Study Group. Burns TM, et al. Among authors: conaway m. Neurology. 2010 May 4;74(18):1434-40. doi: 10.1212/WNL.0b013e3181dc1b1e. Neurology. 2010. PMID: 20439845 Free PMC article.

2

R+ pramipexole as a mitochondrially focused neuroprotectant: initial early phase studies in ALS.

Wang H, Larriviere KS, Keller KE, Ware KA, Burns TM, Conaway MA, Lacomis D, Pattee GL, Phillips LH 2nd, Solenski NJ, Zivkovic SA, Bennett JP Jr. Wang H, et al. Among authors: conaway ma. Amyotroph Lateral Scler. 2008 Feb;9(1):50-8. doi: 10.1080/17482960701791234. Amyotroph Lateral Scler. 2008. PMID: 18270879

3

MG-ADL: still a relevant outcome measure.

Muppidi S, Wolfe GI, Conaway M, Burns TM; MG COMPOSITE AND MG-QOL15 STUDY GROUP. Muppidi S, et al. Among authors: conaway m. Muscle Nerve. 2011 Nov;44(5):727-31. doi: 10.1002/mus.22140. Muscle Nerve. 2011. PMID: 22006686

4

Psychometric evaluation of the myasthenia gravis composite using Rasch analysis.

Sadjadi R, Conaway M, Cutter G, Sanders DB, Burns TM; MG Composite MG-QOL15 Study Group. Sadjadi R, et al. Among authors: conaway m. Muscle Nerve. 2012 Jun;45(6):820-5. doi: 10.1002/mus.23260. Muscle Nerve. 2012. PMID: 22581534

5

International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15r.

Burns TM, Sadjadi R, Utsugisawa K, Gwathmey KG, Joshi A, Jones S, Bril V, Barnett C, Guptill JT, Sanders DB, Hobson-Webb L, Juel VC, Massey J, Gable KL, Silvestri NJ, Wolfe G, Cutter G, Nagane Y, Murai H, Masuda M, Farrugia ME, Carmichael C, Birnbaum S, Hogrel JY, Nafissi S, Fatehi F, Ou C, Liu W, Conaway M. Burns TM, et al. Among authors: conaway m. Muscle Nerve. 2016 Dec;54(6):1015-1022. doi: 10.1002/mus.25198. Epub 2016 Nov 7. Muscle Nerve. 2016. PMID: 27220659

6

The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events.

Hehir MK, Conaway M, Clark EM, Aronzon DB, Kolb N, Kolb A, Ruzhansky K, Sadjadi R, De Sousa EA, Burns TM. Hehir MK, et al. Among authors: conaway m. PLoS One. 2022 Feb 17;17(2):e0262109. doi: 10.1371/journal.pone.0262109. eCollection 2022. PLoS One. 2022. PMID: 35176061 Free PMC article.

7

Measuring treatment adverse event burden in myasthenia gravis: Single-center prospective evaluation utilizing the Adverse Event Unit (AEU).

Hehir MK, Conaway M, St Sauveur AB, Feb K, Kolb NA, Waheed W, McNeish BL, Tweedy N, Burns TM. Hehir MK, et al. Among authors: conaway m. Muscle Nerve. 2024 Jan;69(1):32-39. doi: 10.1002/mus.27966. Epub 2023 Sep 7. Muscle Nerve. 2024. PMID: 37676119

8

Reference data and quantile regression.

Conaway M. Conaway M. Muscle Nerve. 2009 Nov;40(5):751-2. doi: 10.1002/mus.21562. Muscle Nerve. 2009. PMID: 19827090 No abstract available.

9

Tests for order restrictions in binary data.

Peddada SD, Prescott KE, Conaway M. Peddada SD, et al. Among authors: conaway m. Biometrics. 2001 Dec;57(4):1219-27. doi: 10.1111/j.0006-341x.2001.01219.x. Biometrics. 2001. PMID: 11764263

10

A model-assisted design for partially or completely ordered groups.

Celum C, Conaway M. Celum C, et al. Among authors: conaway m. Pharm Stat. 2024 May 20. doi: 10.1002/pst.2396. Online ahead of print. Pharm Stat. 2024. PMID: 38769904

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page